ライフサイエンスコーパス: follow-up care

1 .2 percent for screening to 58.5 percent for follow-up care.

2 ty to seek and receive appropriate long-term follow-up care.

3 ical treatment with a median of 83 months of follow-up care.

4 e aware of this elevated risk to help inform follow-up care.

5 gy consultation in the ED did not return for follow-up care.

6 d with lower rates of antibiotic receipt and follow-up care.

7 and commonly encountered delays in access to follow-up care.

8 alists and avoid exacerbating disparities in follow-up care.

9 visits were less likely to obtain outpatient follow-up care.

10 ion in costs for the index CABG procedure or follow-up care.

11 diagnosis, pre-interventional management and follow-up care.

12 rgency department do not receive recommended follow-up care.

13 ts received treatment; 2725 (55.6%) received follow-up care.

14 f subsequent neoplasms and the importance of follow-up care.

15 survive firearm injuries frequently require follow-up care.

16 rs and respite housing to assure appropriate follow-up care.

17 anters stratify low-risk patients and tailor follow-up care.

18 n patient selection, procedural details, and follow-up care.

19 erapy, monitoring of efficacy, and long-term follow-up care.

20 acteristics associated with obtaining timely follow-up care.

21 can enhance ED screening, intervention, and follow-up care.

22 during the course of illness, treatment, and follow-up care.

23 cancer prevention, diagnosis, treatment, and follow-up care.

24 n is useful in overcoming common barriers to follow-up care.

25 This information is crucial to guide follow-up care.

26 visited dermatologists in their offices for follow-up care.

27 ures need a structured surveillance plan for follow-up care.

28 ted by nephrectomy develop metastasis during follow-up care.

29 cancers completed a mailed survey on cancer follow-up care.

30 ms, and health promotion, is vital to cancer follow-up care.

31 are through delay in intervention or loss of follow-up care.

32 oung male survivors are important aspects of follow-up care.

33 rsement should not be a barrier in providing follow-up care.

34 e similar to the reimbursement for recipient follow-up care.

35 rvivors' perceptions of the quality of their follow-up care.

36 and innovative approaches for transition of follow-up care.

37 ement to the transplant center for providing follow-up care.

38 s to improve the coordination and quality of follow-up care.

39 ntensive inpatient management and subsequent follow-up care.

40 summaries more consistently available during follow-up care.

41 implementation of future models of long-term follow-up care.

42 icians, as well as oncology specialists, for follow-up care.

43 able conditions for which survivors may seek follow-up care.

44 this underuse was not explained by access to follow-up care.

45 osis grade from 5 to 3) during nine years of follow-up care.

46 er variation was explained by differences in follow-up care.

47 ation, emergency department utilization, and follow-up care 30 days after discharge; length of inpati

48 vors should see for cancer-related and other follow-up care (32%); fewer still also provided a writte

49 f HIV-positive users already had a source of follow-up care, 65% accepted referrals, and 12% had test

50 knowledge and optimize each phase of NBS and follow-up care, advancing health outcomes for children w

51 Mobile app follow-up care affects neither complication rates nor pa

52 t pulmonary injury who may require intensive follow-up care after COVID-19.

53 s study examines the incidence of outpatient follow-up care after ED encounters for acute heart failu

54 Our findings highlight the need for improved follow-up care after identification of false-positive ca

55 The median time to subsequent follow-up care after recommendation was 14 days for AI a

56 tal health reason were documented to receive follow-up care although less than 10% of all service mem

57 comfortable with both PCPs and NPs providing follow-up care, although they indicate a preference for

58 nks to advances in diagnosis, treatment, and follow-up care, an ever-increasing number of individuals

59 These findings highlight the need for close follow up care and therapies that slow CKD progression i

60 ls ("Health Links") was developed to enhance follow-up care and broaden the application of the guidel

61 employer assistance and associations between follow-up care and employer assistance were investigated

62 frequently noted in primary care (inadequate follow-up care and high rates of inadequate antidepressa

63 ons in the probability that children receive follow-up care and in the type of follow-up care receive

64 patients at risk of LC is important to offer follow-up care and plan population-level public health m

65 ation, fluid and nutritional management, and follow-up care and risk-reduction strategies, which are

66 Follow-up care and surveillance are essential components

67 state re-biopsy is not necessary as standard follow-up care and that the absence of a rising PSA leve

68 nitoring could be valuable tools for guiding follow-up care and treatment decisions for early-stage N

69 reatable conditions for which survivors seek follow-up care and underscores the need for a multidisci

70 ealth providers, facilitation of appropriate follow-up care, and as-needed outreach and crisis interv

71 is discussed in the context of LD education, follow-up care, and future research on donation benefits

72 in diagnosis, interruption of treatment and follow-up care, and increases in overall infection rates

73 %; Germany) to 129 (95%; Italy) received any follow-up care, and one (10%; Nigeria) to 113 (42%; Fran

74 ng treatment intensification, self-care, and follow-up care are needed to improve hypertension manage

75 ortance of hospital discharge procedures and follow-up care as modifiable factors for mitigating the

76 anges are required to adapt to the extensive follow-up care associated with some of these new treatme

77 Most patients (73%) received outpatient follow-up care at Emory Healthcare within 30 days of dis

78 Veterans Affairs (VA) hospitals and received follow-up care at VA and non-VA hospitals and imaging ce

79 MOs and PCPs perceive different cancer follow-up care barriers/concerns to be problematic.

80 Many centers recommend that donor follow-up care be provided by primary care physicians, b

81 Compared with follow-up care between days 8 and 30, follow-up within a

82 Comprehensive follow-up care by experienced caregivers can be highly e

83 delivery, diagnosis, disease monitoring, and follow-up care can be conducted remotely, resulting in c

84 erventions starting during ICU admission and follow-up care can prevent or mitigate post-ICU problems

85 Asian survivors report poorer follow-up care communication and care quality.

86 ing may inform treatment decision-making and follow-up care considerations in this population.

87 be concerned about problems with organizing follow-up care (corr.

88 ion should be taken into account when making follow-up care decisions.

89 To determine whether follow-up care delivered via a mobile app can be used to

90 ase in reports of inability to afford needed follow-up care (difference-in-differences estimate, -3.4

91 reatment initiation, symptom monitoring, and follow-up care documented within 3 months of initial sym

92 Continued follow-up care, especially in lower income children, may

93 orces the importance of continued, long-term follow-up care following COVID-19 infection, with specia

94 led surveillance is a promising new model of follow-up care following excision of localized melanoma.

95 s of accepted donors+donor hepatectomy+donor follow-up care for 1 year+pretransplant recipient care [

96 medication did not have any documentation of follow-up care for 3 months (n = 356).

97 Cancer (CEASAR Study), Costs and Benefits of Follow-up Care for Adolescent and Young Adult Cancers, S

98 We described follow-up care for breast cancer survivors, examined how

99 mendations inform routine, uniform long-term follow-up care for CAYA survivors of cancer at risk of n

100 cords were queried for sex, age, method, and follow-up care for index attempt survivors.

101 ndents both operate on and provide long-term follow-up care for lung cancer patients.

102 y networks can ensure consistent support and follow-up care for mothers.

103 guidelines are needed to optimize and tailor follow-up care for older patients.

104 iagnostics, treatment options, and long-term follow-up care for patients with an ASD.

105 Follow-up care for patients with bicuspid aortic valve w

106 at promoting CVH discussions during routine follow-up care for survivors and recommendations to cons

107 which could reduce the risk of inconsistent follow-up care for survivors that may drive socioeconomi

108 ions for a range of acceptable approaches to follow-up care for the patient with Fontan circulation.

109 ic attributes that may influence therapy and follow-up care for these patients.

110 determining differential needs of long-term follow-up care for treatment maintenance at screening or

111 In this cohort study that captured follow-up care from the integrated VHA health care syste

112 variant classification is a key component of follow-up care given rapidly changing information in the

113 higher convenience scores than the in-person follow-up care group (incidence rate ratio, 1.39; 95% CI

114 s, vs 1.64 in-person visits in the in-person follow-up care group, for a difference of 0.40 times few

115 pp group, and 33 (51%) were in the in-person follow-up care group.

116 P = .005) than did patients in the in-person follow-up care group.

117 Historically, follow-up care has left some patients with insufficient

118 ng standardized protocols and incentives for follow-up care, has yielded valuable information but has

119 Several models of long-term follow-up care have been developed to address this need.

120 ho received a kidney transplant and received follow up care in our centre between 2009-2019.

121 glaucoma and other eye disease detection and follow-up care in high-risk populations in the United St

122 raft nephropathy (CAN) in patients receiving follow-up care in our unit.

123 ades underscores the importance of long-term follow-up care in patients treated for Hodgkin's disease

124 visits compared with conventional, in-person follow-up care in the first 30 days following ambulatory

125 hite) survivors who had seen a physician for follow-up care in the past 2 years (n = 1,196) composed

126 ounding provision of cancer survivorship and follow-up care in the USA and discuss potential solution

127 Follow-up care includes assessment of side effects from

128 by comprehensively addressing components of follow-up care, including health promotion, prostate can

129 The median length of follow-up care is 8.2 years.

130 sk of developing new chronic conditions, ICU follow-up care is advised and may focus on the identific

131 atients who have medical concerns or whether follow-up care is typically still needed within 72 hours

132 inary coordination, and reducing barriers to follow-up care may be necessary for enhancing genetics v

133 s well as early identification and long-term follow-up care, may help further reduce mortality.

134 ment (n = 3136), and 19% did not receive any follow-up care (n = 854).

135 hrough better education, and compliance with follow-up care needs to be improved to decrease the econ

136 ns (PCPs; n = 1,021) were surveyed regarding follow-up care of breast and colon cancer survivors.

137 velopment of multimodal interventions in the follow-up care of CAYAs.

138 nform COG-LTFU Guideline recommendations for follow-up care of female survivors of childhood cancer t

139 care providers (HCPs); and (4) assessment of follow-up care of participants and measuring the impact

140 Parameters for the follow-up care of patients with mild CHI after emergency

141 ed by the COG to provide recommendations for follow-up care of survivors at risk for long-term compli

142 These findings suggest that follow-up care of survivors of MOD should include econom

143 implementation of new efforts to improve the follow-up care of survivors.

144 heart team-led indication, intervention, and follow-up care of TAVR patients.

145 sease, is essential for the proper long-term follow-up care of these patients.

146 l evaluation, procedural considerations, and follow-up care of thyroid radiofrequency ablation, as we

147 phy testing, monoclonal protein testing, and follow-up care on agreement from the treating physician.

148 s, few studies have addressed the quality of follow-up care or duration of treatment for depressed yo

149 oncerned about infection and problems during follow-up care, patients of higher age - who have a high

150 y highlights the need for targeted long-term follow-up care, physical rehabilitation, mental health s

151 ressed enthusiastic support for receipt of a follow-up care plan.

152 ed with cervical dysplasia do not return for follow-up care, primarily due to treatment being inacces

153 late effects and to standardize and enhance follow-up care provided to survivors of pediatric cancer

154 en receive follow-up care and in the type of follow-up care received across zip codes.

155 However, follow-up care recommendations developed at referral cen

156 This implies that daily ICU care and follow-up care should focus on preventing and mitigating

157 Follow-up care should include psychosocial interventions

158 The Cancer Care Ontario (CCO) Guideline on Follow-up Care, Surveillance Protocol, and Secondary Pre

159 e TBI prevention, education, counseling, and follow-up care to at-risk patients.

160 Delivery of quality follow-up care to cancer survivors may require efforts t

161 uture COG-LTFU Guideline recommendations for follow-up care to improve health and quality of life for

162 o assess practices and barriers in providing follow-up care to living donors, we sent a questionnaire

163 te candidate, along with providing long-term follow-up care to maximize outcome.

164 ges for and barriers to provision of optimal follow-up care to patients and survivors living with can

165 ished in Rheumatology in the UK and provides follow-up care to people with inflammatory arthritis inc

166 patients may benefit from timely outpatient follow-up care to reassess volume status, adjust medicat

167 likely not to have received any recommended follow-up care (UI group: 19.3% uninsured vs 9.2% insure

168 ire referral to an eye care professional for follow-up care using a cutoff of moderate diabetic retin

169 sociodemographics, clinical characteristics, follow-up care variables, and current HRQOL scores with

170 Although the delivery of long-term follow-up care varies substantially--particularly in ter

171 Patients were randomly assigned to receive follow-up care via a mobile app or at an in-person visit

172 ing ambulatory breast reconstruction can use follow-up care via a mobile app to avert in-person follo

173 a mobile app can be used to avert in-person follow-up care visits compared with conventional, in-per

174 Relative to no 30-day care, basic follow-up care was associated with an increased hazard o

175 Follow-up care was coordinated with local physicians.

176 The distribution of time to follow-up care was estimated by using the Kaplan-Meier e

177 The association of parity with follow-up care was increased for enrollees from areas of

178 However, follow-up care was low and substantial variation existed

179 ts were randomly assigned to receive routine follow-up care (well-baby care and care for chronic illn

180 Differences in rates of follow-up care were evident between sites (site 2: OR, 1

181 In the 10 657 patients with rapid follow-up care who were propensity score matched to a pa

182 d recommendations, appointments, or both for follow-up care with physicians as indicated.

183 g costs and copayments, as well as increased follow-up care with prescribing physicians for patients

184 logistic regression; and we examined whether follow-up care with providers of various specialties exp

185 Patients had standard follow-up care with the clinic.

186 Lung-RADS 4B or 4X, adherence was defined as follow-up care within 4 weeks, as ACR Lung-RADS does not